| abstract |
The present invention relates to adenine which is a compound applied to the activation of AMPK (AMP-activated protein kinase), and further provides a drug for preventing or treating a physiological condition or disease using the compound. A drug for treating a physiological condition or disease associated with reactive oxygen species, comprising adenine and / or a pharmaceutically acceptable salt thereof. The drug wherein the physiological condition or disease associated with the reactive oxygen species is Alzheimer's disease, Parkinson's disease, Huntington's chorea or amyotrophic lateral sclerosis. 【Selection chart】 None |